Controlling Alpha Level in Simon’s Two-Stage Design with Overrun or Underrun
Simon’s Two-Stage Design is commonly used in phase II clinical trials to evaluate whether a new treatment shows sufficient promise for further study while minimizing the number of patients exposed to ineffective treatments. The design involves:
- An initial stage (Stage 1) where a small number of patients are enrolled and assessed.
- If promising results are observed, the trial proceeds to Stage 2 with additional patients.
- If the treatment is ineffective in Stage 1, the trial is stopped early.
However, in real-world clinical trials, overruns (exceeding planned sample size) or underruns (fewer patients than planned) can occur due to logistical, operational, or recruitment issues. These deviations can impact the Type I error rate (α level) and the statistical integrity of the trial.
1. Impact of Overrun or Underrun on Alpha Control
A. Overrun (More Patients Enrolled)
- Problem: If more patients are enrolled in Stage 1, there is a higher chance of incorrectly rejecting the null hypothesis (increasing Type I error).
- Solution:
- Strict Stopping Rules: Ensure that patient enrollment stops as soon as the decision boundary is reached.
- Recalculate Critical Values: If the overrun is unavoidable, adjust the rejection criteria for Stage 2 using a recalculated critical value to maintain the overall alpha level.
- Monte Carlo Simulations: Use simulations to evaluate and adjust the design’s Type I error rate.
B. Underrun (Fewer Patients Enrolled)
- Problem: Fewer patients in Stage 1 lead to lower power and could cause an early termination of a potentially effective treatment.
- Solution:
- Combine Data from Stage 1 & 2: If recruitment issues occur, it may be reasonable to combine patients from both stages and reanalyze based on the total observed responses.
- Bayesian Methods: Bayesian adaptive approaches can adjust for uncertainty due to missing data.
2. Statistical Approaches to Control Alpha in Case of Overrun/Underrun
A. Adjusting the Critical Boundaries Post Hoc
- The error probability structure must be controlled using:
- Modified Critical Values: Adjust the threshold for rejecting (null hypothesis).
- Conditional Probability Calculations: Ensure Type I error remains below the pre-specified alpha level.
B. Permutation Testing & Simulation-Based Methods
- Monte Carlo simulations can be used to adjust the alpha level dynamically if deviations occur.
- Bootstrap resampling to assess statistical robustness.
C. Bayesian Alternative
- A Bayesian Simon’s Two-Stage Design uses posterior probabilities to adaptively modify decision boundaries based on observed data.
3. Practical Recommendations for Trial Conduct
- Predefine stopping rules for early termination and clearly state what happens in case of overrun/underrun.
- Monitor recruitment closely to minimize deviations from the planned sample size.
- Apply sensitivity analyses if deviations occur to assess their impact on statistical validity.
Summary
Issue | Impact | Solution |
---|---|---|
Overrun (More patients than planned) | Increases Type I error (false positives) | Stop early, recalculate rejection criteria, use simulations |
Underrun (Fewer patients enrolled) | Reduces power, risk of early termination | Combine stages, Bayesian methods, sensitivity analysis |
Here's a Python implementation to handle overrun and underrun in Simon's Two-Stage Design, including simulations to control the alpha level.
Overview of the Code
- Step 1: Define Simon’s Two-Stage Design parameters (sample size, rejection criteria).
- Step 2: Simulate trial outcomes.
- Step 3: Adjust for overrun or underrun and recalculate the Type I error rate.
- Step 4: Use Monte Carlo simulations to evaluate the impact on the error rate.
Python Code for Handling Overrun/Underrun in Simon’s Two-Stage Design
Explanation of the Code
Simulates Simon’s Two-Stage Design under different scenarios:
- Baseline: No overrun/underrun.
- Overrun: Extra patients in Stage 1.
- Underrun: Fewer patients in Stage 1.
Adjusts sample size dynamically to account for overrun or underrun.
Calculates the adjusted Type I error rate by running Monte Carlo simulations.
Visualizes the impact of overrun and underrun on the alpha level using a bar plot.
Key Findings
- Overrun increases Type I error rate, making it more likely to falsely reject .
- Underrun decreases power, making it harder to detect a true effect.
- Baseline design keeps the error rate within acceptable limits.
How to Use This Code?
- Adjust based on your specific study.
- Modify and for different response rates.
- Change overrun/underrun values to see how deviations affect the trial.
Next Steps
Would you like to extend this:
✔ Add a Bayesian adjustment for overrun?
✔ Include real-world clinical trial data?
✔ Simulate power calculations along with Type I error?
Comments
Post a Comment